Bifurcation stenting: Current strategies and new devices

Heart

Volumn 95, Issue 6, 2009, Pages 495-504

  Latib, A ^a,b   Colombo, A ^a,c   Sangiorgi, G M ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN;

BALLOON DILATATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BIFURCATION; CORONARY STENT; DRUG ELUTING STENT; EQUIPMENT DESIGN; HEART INFARCTION; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; THERAPY EFFECT; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; HUMANS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STENTS;

EID: 61949298609     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.150391     Document Type: Review

References (28)

1. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 2006;114:1955-61.
2. Thuesen L, Kelbaek H, Klovgaard L, et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). Am Heart J 2006;152:1140-5.
3. Ge L, Tsagalou E, Iakovou I, et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:757-60.
4. Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol 2005;46:633-7.
5. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-9.
6. Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-64.
7. Colombo A. CACTUS trial (Coronary bifurcation Application of the Crush Technique Using Sirolimus-eluting stents): 6-month clinical and angiographic results. Presented at EuroPCR 2008 in Barcelona, Spain on 13 May 2008. Available at http://www.europcronline.com/fo/lecture/view-slide.php? idCongres=4&id=5899 (accessed 6 November 2008).
8. Ferenc M, Gick M, Kienzle R-P, et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J 2008 Oct 9 [Epub ahead of print].
9. Tsuchida K, Colombo A, Lefevre T, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J 2007;28:433-42.
10. Ge L, Iakovou I, Cosgrave J, et al. Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting. Heart 2006;92:371-6.
11. Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? J Am Coll Cardiol Intv 2008;1:218-26.
12. Weinstein JS, Baim DS, Sipperly ME, et al. Salvage of branch vessels during bifurcation lesion angioplasty: acute and long-term follow-up. Cathet Cardiovasc Diagn 1991;22:1-6.
13. Abizaid A, De Ribamar Costa J, Alfaro VJ, et al. Bifurcated stents: giving to Caesar what is Caesar's. Eurointervention 2007;2:518-25.
14. Solar RJ. The Y Med sidekick stent delivery system for the treatment of coronary bifurcation and ostial lesions. Presented at Cardiovascular Revascularization Therapies (CRT) 2007 in Washington DC on 8 March 2007. Available at http://www.crtonline.org/flash.aspx?PAGE-ID=4328 (accessed 6 November 2008).
15. Lefevre T, Ormiston J, Guagliumi G, et al. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am Coll Cardiol 2005;46:592-8.
16. Lefevre T. On behalf of the Desire Investigators. Invatec twin rail bifurcation stent. Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2005 in Washington D.C. Available at http://www.tctmd.com/Show.aspx?id= 68990 (accessed 6 November 2008).
17. Lefevre T, Pavlides G On behalf of the Nile Registry investigators. Main results of the Nile Registry. Available at http://www.bifurc.net/files/medtool/webmedtool/icpstool01/stud0112/html/Nile/ frame.htm (accessed 6 November 2008).
18. Ikeno F, Kim YH, Luna J, et al. Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study. Catheter Cardiovasc Interv 2006;67:198-206.
19. Laborde JC, Borenstein N, Behr L, et al. Stentys coronary bifurcation stent. Eurointervention 2007;3:162-5.
20. Grube E. New dedicated side branch stents. Presented at EuroPCR 2008 in Barcelona, Spain on 15 May 2008. Available at http://www.europcronline. com/fo/lecture/view-slide.php?id=5898 (accessed 6 November 2008).
21. Ormiston J, Webster M, El-Jack S, et al. The AST petal dedicated bifurcation stent: first-in-human experience. Catheter Cardiovasc Interv 2007;70:335-40.
22. Costa RA, Abizaid A, Abizaid A, et al. Preliminary results of the novel TMI (TriReme Medical Inc) Antares side branch adaptive system (Antares SAS™ Stent) for the treatment of de novo coronary bifurcation lesions - SCAI-ACCi2 Interventional E-Abstract 2900-123. J Am Coll Cardiol 2008;51:B51.
23. Grube E, Wijns W, Schofer J, et al. FIM results of Cappella Sideguard™ for treatment of coronary bifurcations. Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2007 in Washington DC on 21 October 2007.
24. Kaplan AV, Ramcharitar S, Louvard Y, et al. Tryton I, first-in-man (FIM) study: acute and 30 day outcome. A preliminary report. Eurointervention 2007;3:54-9.
25. Onuma Y, Mülle R, Ramcharitar S, et al. Tryton I, first-in-man (FIM) study: six month clinical outcome and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions Eurointervention 2008;3:546-52.
26. Grube E, Buellesfeld L, Neumann FJ, et al. Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. Am J Cardiol 2007;99:1691-7.
27. Ramcharitar S, Gaster AL, Daemen J, et al. Drug-eluting stents, restenosis and revascularization. Herz 2007;32:287-95.
28. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent - immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-51.